IRG
Tuesday 14th January 2014 |
Text too small? |
Mainfreight Ltd (MFT: NZX) is a global supply chain logistics provider, with businesses operating in 214 branches throughout New Zealand, Australia, the Netherlands, Belgium, France, Poland, Romania, Russia, Finland, China, Hong Kong, Singapore, Chile and the United States. The Company provides its customers service across a range of logistics services, which include Managed Warehousing, Domestic Distribution, Metro and Wharf Cartage and International Air and Sea Freight operations. On April 1, 2011, the Company acquired Wim Bosman Group in Europe. The company's origins go back to 1978 and listing was achieved in June 1996 following sale of 60% of the shares on issue by founders Bruce Plested and Neil Graham at 96c each.
Performance for First Half of FY2013
During the second quarter, EBITDA improved 26.6% and revenue lifted 3.1% over the first quarter's performance. Regionally, Australasia and Asia have contributed strongly, while results from Europe and the Americas are disappointing. [Source: Mainfreight Annual Report 2013 & NZX Announcements]
Trading during the first three months of the 2014 financial year saw reduced volumes and profitability across most of the Mainfreight network, however performance through August and September improved and this has continued through October and into November.
The Directors are satisfied with the direction and development of the Group. The next twelve months will continue the developments that Mainfreight has undertaken. The company said it expects to lift earnings in the current year, with measures put in place to improved trading at Mainfreight USA likely to show up in the fourth quarter, while Europe will take longer to improve.
The share is trading at $12.46 as of 13th Jan, 2014.
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors